Wednesday July 27, 2016 0 comments
LOVELAND -- The Northern Colorado Bioscience Cluster (NoCoBio) will host “The Precision Medicine Summit” on July 29 to spotlight advances in tailored medical treatment.
NoCoBio said advances in precision medicine have led to new discoveries and treatments tailored to specific characteristics of individuals, such as a person’s genetic makeup or the genetic profile of an individual’s tumor.
Speakers at the event, set for 1-6 p.m. at Medical Center of the Rockies, include:
- Alan Rudolph, CSU VP of research
- Kevin Unger, MCR CEO
- Deanna Scott, NoCoBio executive director
The event will also include a presentation by Biodesix on the use of molecular profiling for cancer biomarker discovery; innovation in cytogenics to advance precision medicine by Chris Tompkins, KromaTiD CEO; a presentation on precision medicine in oncology by Dr. Steven Schuster, UC Health North; and a Catholic Health Initiatives response to Vice President Joe Biden’s Cancer Moonshot program.
Partners in the event include University of Colorado Health, Colorado State University, CSU Ventures, City of Fort Collins, Innosphere and Colorado BioScience Association.
For register or for more information, click here.